BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24798673)

  • 1. Should doxylamine-pyridoxine be used for nausea and vomiting of pregnancy?
    Persaud N; Chin J; Walker M
    J Obstet Gynaecol Can; 2014 Apr; 36(4):343-348. PubMed ID: 24798673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing pyridoxine and doxylamine succinate-pyridoxine HCl for nausea and vomiting of pregnancy: A matched, controlled cohort study.
    Pope E; Maltepe C; Koren G
    J Clin Pharmacol; 2015 Jul; 55(7):809-14. PubMed ID: 25663469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new pharmacologic treatment for nausea and vomiting of pregnancy.
    Fantasia HC
    Nurs Womens Health; 2014; 18(1):73-77. PubMed ID: 24548499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy.
    Koren G; Clark S; Hankins GD; Caritis SN; Umans JG; Miodovnik M; Mattison DR; Matok I
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):371. PubMed ID: 27881103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA approval of doxylamine-pyridoxine therapy for use in pregnancy.
    Slaughter SR; Hearns-Stokes R; van der Vlugt T; Joffe HV
    N Engl J Med; 2014 Mar; 370(12):1081-3. PubMed ID: 24645939
    [No Abstract]   [Full Text] [Related]  

  • 6. Flawed invisible trial underpins US morning sickness drug, researchers say.
    Dyer O
    BMJ; 2017 Jan; 356():j132. PubMed ID: 28069575
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating morning sickness in the United States--changes in prescribing are needed.
    Koren G
    Am J Obstet Gynecol; 2014 Dec; 211(6):602-6. PubMed ID: 25151184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxylamine/pyridoxine for nausea and vomiting in pregnancy.
    Drug Ther Bull; 2019 Mar; 57(3):38-41. PubMed ID: 30705026
    [No Abstract]   [Full Text] [Related]  

  • 9. Studying the antiemetic effect of vitamin B6 for morning sickness: pyridoxine and pyridoxal are prodrugs.
    Matok I; Clark S; Caritis S; Miodovnik M; Umans JG; Hankins G; Mattison DR; Koren G
    J Clin Pharmacol; 2014 Dec; 54(12):1429-33. PubMed ID: 25052410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of doxylamine-pyridoxine for morning sickness.
    Koren G; Hankins GD; Clark S; Caritis SN; Miodovnik M; Umans JG; Mattison DR
    Am J Obstet Gynecol; 2016 May; 214(5):664-6. PubMed ID: 26844757
    [No Abstract]   [Full Text] [Related]  

  • 11. 8-Way Randomized Controlled Trial of Doxylamine, Pyridoxine and Dicyclomine for Nausea and Vomiting during Pregnancy: Restoration of Unpublished Information.
    Zhang R; Persaud N
    PLoS One; 2017; 12(1):e0167609. PubMed ID: 28052111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nausea and vomiting of pregnancy.
    Madjunkova S; Maltepe C; Koren G
    Paediatr Drugs; 2014 Jun; 16(3):199-211. PubMed ID: 24574047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of women with nausea and vomiting of pregnancy who chose to continue compassionate use of placebo after a randomised trial.
    Matok I; Umans J; Feghali MN; Clark S; Caritis S; Miodovnik M; Hankins G; Mattison DR; Nordeng H; Koren G
    J Obstet Gynaecol; 2013 Aug; 33(6):557-60. PubMed ID: 23919849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The return to the USA of doxylamine-pyridoxine delayed release combination (Diclegis®) for morning sickness--a new morning for American women.
    Koren G
    J Popul Ther Clin Pharmacol; 2013; 20(2):e161-2. PubMed ID: 23863487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation of Bendectin.
    Jick SS; Garrison JM
    Am J Public Health; 1988 Mar; 78(3):322-3. PubMed ID: 3341508
    [No Abstract]   [Full Text] [Related]  

  • 16. Critical appraisal of drug therapy for nausea and vomiting of pregnancy: II. Efficacy and safety of diclectin (doxylamine-B6).
    Bishai R; Mazzotta P; Atanackovic G; Levichek Z; Pole M; Magee LA; Koren G
    Can J Clin Pharmacol; 2000; 7(3):138-43. PubMed ID: 11044759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Return of the morning sickness pill. Could Bendectin be coming back to market?
    AWHONN Lifelines; 2001; 5(1):22-3. PubMed ID: 11941692
    [No Abstract]   [Full Text] [Related]  

  • 18. Diclegis: return of a medication.
    Hansen KA
    S D Med; 2013 Dec; 66(12):495. PubMed ID: 24527546
    [No Abstract]   [Full Text] [Related]  

  • 19. American Gastroenterological Association institute medical position statement on the use of gastrointestinal medication in pregnancy.
    Staroselsky A; Garcia-Bournissen F; Koren G
    Gastroenterology; 2007 Feb; 132(2):824-5; author reply 825. PubMed ID: 17261292
    [No Abstract]   [Full Text] [Related]  

  • 20. New evidence for concern over the risk of birth defects from medications for nausea and vomitting of pregnancy.
    Bérard A; Sheehy O; Gorgui J; Zhao JP; Soares de Moura C; Bernatsky S
    J Clin Epidemiol; 2019 Dec; 116():39-48. PubMed ID: 31352006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.